Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Restless Legs Syndrome”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07224932
What this trial is testing

Tolerability and Efficacy of CBD Extract for RLS Treatment

Who this might be right for
Restless Leg Syndrome
University of Colorado, Denver 60
Testing effectiveness (Phase 2)Study completedNCT02231918
What this trial is testing

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)Study completedNCT00389831
What this trial is testing

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

Who this might be right for
Restless Legs Syndrome
UCB Pharma 44
Testing effectiveness (Phase 2)Study completedNCT00239486
What this trial is testing

Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 109
Not applicableStudy completedNCT04827329
What this trial is testing

Anesthetic Management of Patients With Chronic Sleep Disorders

Who this might be right for
NarcolepsyIdiopathic HypersomniaRestless Legs Syndrome
University Hospital, Montpellier 700
Large-scale testing (Phase 3)Study completedNCT00263068
What this trial is testing

An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 279
Testing effectiveness (Phase 2)Ended earlyNCT00834327
What this trial is testing

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
Neurogen Corporation 230
Post-approval studies (Phase 4)Study completedNCT00356096
What this trial is testing

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances

Who this might be right for
Restless Legs SyndromeDepression
Boehringer Ingelheim 404
Large-scale testing (Phase 3)Study completedNCT00275236
What this trial is testing

A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 60
Testing effectiveness (Phase 2)Study completedNCT00498186
What this trial is testing

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
UCB Pharma 295
Large-scale testing (Phase 3)Study completedNCT01112644
What this trial is testing

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

Who this might be right for
Moderate to Severe Idiopathic RLS With Daytime Symptoms
Mundipharma Research GmbH & Co KG 205
Testing effectiveness (Phase 2)Study completedNCT00666965
What this trial is testing

A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients

Who this might be right for
Idiopathic Restless Legs Syndrome
Otsuka Pharmaceutical Co., Ltd. 230
Post-approval studies (Phase 4)Study completedNCT01823770
What this trial is testing

Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome (RLS)
University Hospital, Montpellier 130
Post-approval studies (Phase 4)Study completedNCT01455012
What this trial is testing

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB BIOSCIENCES GmbH 81
Testing effectiveness (Phase 2)Study completedNCT01521663
What this trial is testing

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Impax Laboratories, LLC 159
Large-scale testing (Phase 3)Study completedNCT00390689
What this trial is testing

A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.

Who this might be right for
Idiopathic Restless Legs Syndrome
Boehringer Ingelheim 154
Post-approval studies (Phase 4)Study completedNCT00349531
What this trial is testing

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 369
Large-scale testing (Phase 3)Study completedNCT00135993
What this trial is testing

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 811
Post-approval studies (Phase 4)Study completedNCT00375284
What this trial is testing

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 404
Not applicableLooking for participantsNCT05321355
What this trial is testing

Mainz Register of Patients With Sleep Disorders

Who this might be right for
Sleep DisorderSleep Disorder ParasomniaNarcolepsy+6 more
Johannes Gutenberg University Mainz 500
Next Page